Breast cancer—major changes in the American Joint Committee on Cancer eighth edition cancer staging manual

AE Giuliano, JL Connolly, SB Edge… - CA: a cancer journal …, 2017 - Wiley Online Library
Answer questions and earn CME/CNE The revision of the eighth edition of the primary
tumor, lymph node, and metastasis (TNM) classification of the American Joint Commission of
Cancer (AJCC) for breast cancer was determined by a multidisciplinary team of breast
cancer experts. The panel recognized the need to incorporate biologic factors, such as
tumor grade, proliferation rate, estrogen and progesterone receptor expression, human
epidermal growth factor 2 (HER2) expression, and gene expression prognostic panels into …

Breast cancer: current molecular therapeutic targets and new players

S Nagini - Anti-Cancer Agents in Medicinal Chemistry …, 2017 - ingentaconnect.com
Breast cancer is the most common cancer and the most frequent cause of cancer death
among women worldwide. Breast cancer is a complex, heterogeneous disease classified
into hormone-receptor-positive, human epidermal growth factor receptor-2 overexpressing
(HER2+) and triple-negative breast cancer (TNBC) based on histological features.
Endocrine therapy, the mainstay of treatment for hormone-responsive breast cancer involves
use of selective estrogen receptor modulators (SERMs), selective estrogen receptor …